Related Experiment Video
Updated: Jan 26, 2026

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
Hodgkin disease therapy induced second malignancy susceptibility 6q21 functional variants in roma and hungarian
Dalma Varszegi1, Balazs Duga, Bela I Melegh
1Department of Dermatology, Venereology and Oncodermatology, University of Pecs, Pecs, Hungary.
Abstract:
Patients treated successfully for pediatric Hodgkin's lymphoma are known to develop secondary malignancies; care is already taken in treatment to prevent this adverse effect. Recent GWAS study identified rs4946728 and rs1040411 noncoding SNPs located between PRDM1 and ATG1 genes on chromosome 6q21 as risk factors for secondary malignancies in patients formerly treated with radiotherapy for pediatric Hodgkin disease. We investigated the allele frequencies of these two SNPs in biobanked, randomly selected DNA of average, apparently healthy Hungarians (n = 277) and in samples of Roma (n = 279) population living Hungary. The risk allele frequency for rs4946728 was 79.4 % in Hungarian and 83.5 % in Roma samples, while for rs1040411 it was 56.4 % in Hungarian and 55.8 % in Roma samples. These values are quite similar in the two populations, and are rather high. The values are higher than those frequencies observed in the controls (rs4946728: 59.1 % and rs1040411: 39.6 %, p < 0.05), and are in the range of the cases (86 % and 68.2 %, respectively) of the above original GWAS study. Our findings suggest, that beside the already taken precautions, genetic characterization of Hungarian pediatric Hodgkin patients seems to be advantageous prior to the treatment of their disease.
Insights
Genetic variants increase secondary cancer risk in pediatric Hodgkin
Area of Science:
- Genetics
- Oncology
- Epidemiology
Background:
- Pediatric Hodgkin's lymphoma survivors face increased risk of secondary malignancies.
- Radiotherapy for Hodgkin's lymphoma is a known risk factor for these secondary cancers.
- Genome-wide association studies (GWAS) identified specific SNPs associated with secondary malignancy risk.
Purpose of the Study:
- To investigate the allele frequencies of two specific SNPs (rs4946728 and rs1040411) in Hungarian and Roma populations.
- To compare these frequencies with control groups and previously identified case data.
- To assess the potential benefit of genetic characterization in Hungarian pediatric Hodgkin's lymphoma patients.
Main Methods:
- Analysis of DNA samples from randomly selected, apparently healthy individuals from Hungarian (n=277) and Roma (n=279) populations.
- Genotyping of single nucleotide polymorphisms (SNPs) rs4946728 and rs1040411.
- Comparison of allele frequencies with existing control and case data from a prior GWAS.
Main Results:
- High risk allele frequencies for rs4946728 (Hungarian: 79.4%, Roma: 83.5%) and rs1040411 (Hungarian: 56.4%, Roma: 55.8%) were observed.
- These frequencies were significantly higher than in control populations.
- The observed frequencies were comparable to those found in patients who developed secondary malignancies.
Conclusions:
- The studied SNPs show high allele frequencies in both Hungarian and Roma populations.
- These findings suggest a potential genetic predisposition to secondary malignancies in these populations.
- Genetic screening prior to treatment could aid in managing secondary malignancy risk for Hungarian pediatric Hodgkin's lymphoma patients.
Related Concept Videos
Sample Proportion and Population Proportion
Histone Variants at the Centromere
Conservation of Small Populations
What is Population Genetics?
Population Growth
Gene Therapy

